Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

Health experts presented findings showing the drugs helped severely obese youngsters shed pounds on top of the diet and ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Giving obese children weight-loss jabs is effective and helps prevent battles around mealtimes, researchers say. Experts at ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...

Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in ...